The Center for Respiratory Biology and Therapeutics brings together scientific research teams to build a transformative “bench to bedside and back” effort to drive the next phase of discoveries and novel therapeutics for pediatric respiratory diseases.
The Center for Respiratory Biology and Therapeutics is home to the coordinating center of the most clinical studies conducted in the largest cystic fibrosis clinical trials network in the world, bringing together experts from across North America to evaluate the safety and efficacy of new therapies, including cell- and gene-based approaches.
Propelled by innovative research and putting scientific findings to practice, Seattle Children's pediatric pulmonary and lung surgery program is ranked among the top ten in the nation. Through scientific collaboration and innovation, the Center for Respiratory Biology and Therapeutics aims to improve care for children with respiratory disease and train the next generation of respiratory researchers.
Research Areas of Focus
The Center for Respiratory Biology and Therapeutics' physician-scientists lead basic, translational, clinical, epidemiologic and global health research to develop and implement new respiratory therapies across a range of research focus areas.
- Cystic fibrosis
- Asthma
- Chronic lung disease of prematurity
- Congenital and acquired structural airway and lung diseases
- Acute and chronic respiratory failure
- Novel respiratory support technologies
- Novel technologies to deliver inhaled medications
- Sleep disordered breathing
- Primary ciliary dyskinesia
- Respiratory global health research
- Interstitial lung disease
- Pulmonary hypertension
- Respiratory quality improvement research
The center includes world leaders in respiratory global health research. Learn about the Center for Respiratory Biology and Therapeutics' members on the Meet Our Members page.